Simeone, D M <br/><br/>
Ca2+ signaling through secretagogue and growth factor receptors on pancreatic AR42J cells.  [electronic resource] 

 -  Regulatory peptides  Jan 1995 
 - 197-206 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0167-0115 
<br/><br/><label>Standard No.: </label>10.1016/0167-0115(94)00107-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--pharmacology<br/>Animals<br/>Binding Sites<br/>Bombesin--pharmacology<br/>Bradykinin--pharmacology<br/>Calcitonin Gene-Related Peptide--pharmacology<br/>Calcium--metabolism<br/>Carbachol--pharmacology<br/>Cholecystokinin--pharmacology<br/>Epidermal Growth Factor--pharmacology<br/>Estrenes--pharmacology<br/>Fibroblast Growth Factors--pharmacology<br/>GTP-Binding Proteins--metabolism<br/>Hydrolysis<br/>Inositol Phosphates--metabolism<br/>Neuropeptides--pharmacology<br/>Neurotransmitter Agents--pharmacology<br/>Pancreas--cytology<br/>Pancreatic Neoplasms--pathology<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Protein-Tyrosine Kinases--metabolism<br/>Pyrrolidinones--pharmacology<br/>Rats<br/>Receptors, Neuropeptide--metabolism<br/>Substance P--pharmacology<br/>Tumor Cells, Cultured<br/>Type C Phospholipases--antagonists & inhibitors